38.09
-0.08(-0.21%)
Currency In USD
| Previous Close | 38.17 |
| Open | 37.88 |
| Day High | 38.96 |
| Day Low | 37.01 |
| 52-Week High | 58.77 |
| 52-Week Low | 29.24 |
| Volume | 502,256 |
| Average Volume | 548,566 |
| Market Cap | 1.93B |
| PE | 146.5 |
| EPS | 0.26 |
| Moving Average 50 Days | 36.98 |
| Moving Average 200 Days | 37.58 |
| Change | -0.08 |
If you invested $1000 in Vericel Corporation (VCEL) 10 years ago, it would be worth $18,052.13 as of February 21, 2026 at a share price of $38.09. Whereas If you bought $1000 worth of Vericel Corporation (VCEL) shares 5 years ago, it would be worth $786.33 as of February 21, 2026 at a share price of $38.09.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Vericel to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 26, 2026
GlobeNewswire Inc.
Feb 12, 2026 1:30 PM GMT
CAMBRIDGE, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will report its fourth-quarter and full-yea
Vericel Announces Preliminary 2025 Financial Results and Business Updates
GlobeNewswire Inc.
Jan 13, 2026 2:00 PM GMT
Total Revenue Expected to be $276 Million MACI Revenue Expected to be $239.5 Million Fourth Quarter Total Revenue and MACI Revenue Growth of 23% CAMBRIDGE, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in adv
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026
GlobeNewswire Inc.
Jan 06, 2026 1:30 PM GMT
CAMBRIDGE, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will present at the 44th Annual J.P. Morgan